Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALStandard

CLINDAMYCIN PALMITATE HYDROCHLORIDE

CLINDAMYCIN PALMITATE HYDROCHLORIDE

Standard Dose
EQ 75MG BASE/5ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview CLINDAMYCIN PALMITATE HYDROCHLORIDE is listed in Drugs@FDA under application 207047 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient CLINDAMYCIN PALMITATE HYDROCHLORIDE Form and strength FOR SOLUTION;ORAL - EQ 75MG BASE/5ML Sponsor SOMERSET THERAPS LLC Submission history Latest submission status date: 2018-05-11 00:00:00.

Structured Monograph

Clinical summary

Approval overview CLINDAMYCIN PALMITATE HYDROCHLORIDE is listed in Drugs@FDA under application 207047 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient CLINDAMYCIN PALMITATE HYDROCHLORIDE Form and strength FOR SOLUTION;ORAL - EQ 75MG BASE/5ML Sponsor SOMERSET THERAPS LLC Submission history Latest submission status date: 2018-05-11 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.